Jonah Comstock

September 18, 2018
Silicon Valley home diagnostics company Scanadu, best known for its Indiegogo smash hit and Tricorder X-Prize competitor the Scanadu Scout, is coming back into the spotlight after a few years, now with a new name: inui Health. The company announced today that it has received FDA clearance for its smartphone-enabled home urine testing platform that can conduct five common tests, with more to come...
September 17, 2018
Apple may be moving towards commoditizing the on-the-wrist ECG, but other companies in the space aren’t resting on their laurels. AliveCor, which has offered an smartphone-connected ECG since 2012 and a wristworn version since 2016, revealed today the company’s next direction: a six-lead ECG compatible with a smartphone. “For the last year our challenge has not … been in making our devices...
poll results graphic
September 17, 2018
Last week, as part of our Focus on Innovation, HIMSS Media ran a poll about the FDA's Pre-Cert program. The program isn't new, but we thought it would be a good moment to take the public pulse on a program that has seen a variety of reactions from inside the industry. Just under 500 readers responded. In general, those opposed the program constituted a vocal minority — just 7.1 percent of...
September 13, 2018
Yesterday, Apple dropped a bombshell on the digital health world, as it is prone to do in its highly-produced launch events. While the announcement included fall detection on the Apple Watch and some improvements to heart rate monitoring, the headline was definitely the announcement that the Apple Watch Series 4 would contain an FDA-cleared ECG sensor. While much of the reaction has been positive...
September 13, 2018
Dr. Kelly Gebo, a Johns Hopkins professor and expert on HIV research, has joined NIH's All of Us Research Program in the key role of Chief Medical and Scientific Officer. Gebo will "lead the program's scientific agenda" according to the NIH, with a particular focus on including under-represented populations.  “Kelly has the right combination of research skills, leadership experience, and passion...
September 12, 2018
Consumer health software maker Welltok has made another acquisition, this one a long-time player in the digital and mobile health spaces: Wellpass, the company formed in 2017 from a merger of Sense Health and Voxiva. The terms of the deal were not disclosed. "Wellpass is a natural extension of the tremendous work we have been doing to enable health entities to activate consumers by targeting and...
Apple Watch with ECG feature
September 12, 2018
Well, we finally know what cardiac project Apple was talking with the FDA about two years ago. Apple Chief Operating Officer Jeff Williams announced today at Apple's special event in Cupertino that the company has received FDA clearance for both an atrial fibrillation-detecting algorithm and an ECG that will be built into the company's Series 4 Apple Watch, due to start shipping September 21. ...
September 12, 2018
Stanford University is using VivaLNK’s Vital Scout, an adhesive wearable that can track ECG, heart rate variability, respiratory rates, activity, and sleep, in a study on the links between depression and stress. VivaLNK has lent 50 devices to the Stanford research team. “It is known that stress is an underlying cause for various types of health issues," CEO Jiang Li told MobiHealthNews. "Until...
September 11, 2018
InfoBionic, a Lowell, Massachusetts-based remote patient monitoring company, has raised $50 million in a new round of funding. Eagle Investments, Excel Venture Management, Safeguard Scientifics, Zaffre Investments (a subsidiary of Blue Cross Blue Shield of Massachusetts), and Blue Cross and Blue Shield of Kansas all contributed to the round. This round brings the company's total funding up to at...
September 11, 2018
The Cadillac of gene tests? 23andMe is considering a $749 premium gene test offering, considerably more expensive than the $99 to $199 products the company has offered thus far, CNBC reports. Some users received email notifications about a premium service at that price, but clicking the link did nothing. According to 23andMe, it’s only testing user interest and has no plans for a roll out. In...